Search

everythinglearnresearchcommunity

for

Search:↓

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

A new one-step test can quickly identify skin cancer during surgery.

CD200- cells in hair follicles have a higher ability to regenerate hair.

Anti-CD19 therapy may help treat SLE and NMOSD.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Soluble CD83 speeds up wound healing and reduces scarring.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Dual TCR Treg cells are common in mouse tissues and vary by location.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.